Skip to main content
Terug
Watch Compare

Emergent BioSolutions Inc.

Datakwaliteit: 100%
EBS
NYSE Manufacturing Chemicals
€ 8,44
▲ € 0,05 (0,60%)
Marktkapitalisatie: 436,95 M
Prijs
€ 8,44
Marktkapitalisatie
436,95 M
Dagbereik
€ 8,27 — € 8,53
52-Weeksbereik
€ 4,13 — € 14,06
Volume
229.645
Openen € 8,25
50D / 200D Gem.
€ 9,68
12,82% below
50D / 200D Gem.
€ 9,46
10,79% below

Quick Summary

Belangrijkste Punten

Revenue declined -19,77% annually over 5 years
Generating 156,80 M in free cash flow
P/E of 8,31 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,04%
Cash machine — converts 298,10% of earnings into free cash flow
Capital efficient — spends only 1,86% of revenue on capex

Groei

Revenue Growth (5Y)
-19,77%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-28,81%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
9,40%
Boven sectorgemiddelde (-53,47%)
ROIC4,86%
Net Margin7,08%
Op. Margin13,47%

Veiligheid

Debt / Equity
1,19
Boven sectorgemiddelde (0,31)
Current Ratio5,76
Interest Coverage1,69

Waardering

PE (TTM)
8,31
Boven sectorgemiddelde (-1,47)
P/B Ratio0,75
EV/EBITDA4,52
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E 8,3 -1,5
P/B 0,8 1,6
ROE % 9,4 -53,5
Net Margin % 7,1 -41,5
Rev Growth 5Y % -19,8 1,8
D/E 1,2 0,3

ETFs Holding This Stock

ICPY logo ICPY Tweedy, Browne International Insider + Value ETF
1,91% weight
ACAFX ACAFX
1,52% weight
MEQAX MEQAX
1,52% weight
ACCOX ACCOX
1,52% weight
ACVRX ACVRX
1,52% weight
ACVDX ACVDX
1,52% weight
ACEVX ACEVX
1,52% weight
ACVUX ACVUX
1,52% weight
COPY logo COPY Tweedy, Browne Insider + Value ETF
1,15% weight
IFTAX IFTAX
0,75% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -28,81% Revenue Growth (3Y) -15,86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -19,77% Earnings Growth (5Y) -30,91%
Profitability
Revenue (TTM) 742,90 M Net Income (TTM) 52,60 M
ROE 9,40% ROA 3,66%
Gross Margin N/A Operating Margin 13,47%
Net Margin 7,08% Free Cash Flow (TTM) 156,80 M
ROIC 4,86% FCF Growth (3Y) N/A
Safety
Debt / Equity 1,19 Current Ratio 5,76
Interest Coverage 1,69 Asset Turnover 0,52
Working Capital 650,40 M Tangible Book Value 129,80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 8,31 Forward P/E N/A
P/B Ratio 0,75 P/S Ratio 0,59
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4,52 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 35,89%
Market Cap 436,95 M Enterprise Value 884,55 M
Per Share
EPS (Diluted TTM) 0,93 Revenue / Share 14,35
FCF / Share 3,03 OCF / Share 3,30
EPS CAGR (1Y) N/A EPS CAGR (5Y) -31,69%
EPS CAGR (10Y) -2,14%
Efficiency
CapEx / Revenue 1,86% FCF Conversion 298,10%
SBC-Adj. FCF 140,00 M Growth Momentum -9,04

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 742,90 M 1,04 B 1,05 B 1,12 B 1,79 B
Net Income 52,60 M -190,60 M -760,50 M -223,80 M 230,90 M
EPS (Diluted) 0,93 -3,60 -14,85 -4,47 4,27
Gross Profit — — 317,60 M 385,80 M —
Operating Income 100,10 M -108,70 M -726,40 M -172,70 M 352,60 M
EBITDA — — — — —
R&D Expenses 53,20 M 70,70 M 111,40 M 193,00 M 234,00 M
SG&A Expenses 186,10 M 308,00 M 368,40 M 340,30 M 348,40 M
D&A 95,80 M 108,80 M 125,10 M — —
Interest Expense 59,30 M 71,00 M 87,90 M 37,30 M 34,50 M
Income Tax 30,20 M 47,70 M 29,30 M 2,10 M 83,50 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,32 B 1,39 B 1,82 B 3,17 B 2,96 B
Total Liabilities 796,00 M 906,90 M 1,17 B 1,78 B 1,34 B
Shareholders' Equity 522,60 M 482,80 M 649,30 M 1,38 B 1,62 B
Total Debt 589,70 M 700,00 M 868,40 M 1,41 B 849,60 M
Cash & Equivalents 205,40 M 99,50 M 111,70 M 642,60 M 576,10 M
Current Assets 662,50 M 598,70 M 679,50 M 1,21 B 1,27 B
Current Liabilities 132,20 M 162,40 M 651,30 M 1,23 B 373,80 M